vs
Certara, Inc.（CERT）与STONERIDGE INC（SRI）财务数据对比。点击上方公司名可切换其他公司
STONERIDGE INC的季度营收约是Certara, Inc.的2.0倍（$205.2M vs $103.6M），Certara, Inc.同比增速更快（3.3% vs -6.0%），Certara, Inc.自由现金流更多（$27.8M vs $2.6M），过去两年Certara, Inc.的营收复合增速更高（3.6% vs -7.4%）
Certara是全球领先的生物制药软件及咨询服务提供商，专注于建模模拟、监管科学领域的解决方案，服务药企、生物技术企业及医疗相关方，覆盖药物研发全周期，助力加快新疗法上市，降低研发风险与综合成本。
Stoneridge Inc是全球领先的电气电子元件、集成系统及传感器解决方案设计制造商，服务汽车、商用车、非道路设备与航空航天领域，产品可提升车辆安全性、运行效率、互联性与环保表现，业务覆盖全球核心市场。
CERT vs SRI — 直观对比
营收规模更大
SRI
是对方的2.0倍
$103.6M
营收增速更快
CERT
高出9.3%
-6.0%
自由现金流更多
CERT
多$25.2M
$2.6M
两年增速更快
CERT
近两年复合增速
-7.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $103.6M | $205.2M |
| 净利润 | $-5.9M | — |
| 毛利率 | — | 16.2% |
| 营业利润率 | 0.8% | -14.4% |
| 净利率 | -5.7% | — |
| 营收同比 | 3.3% | -6.0% |
| 净利润同比 | -189.6% | — |
| 每股收益（稀释后） | $-0.04 | $-2.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CERTSRI
| Q4 25 | $103.6M | $205.2M | ||
| Q3 25 | $104.6M | $210.3M | ||
| Q2 25 | $104.6M | $228.0M | ||
| Q1 25 | $106.0M | $217.9M | ||
| Q4 24 | $100.4M | $218.2M | ||
| Q3 24 | $94.8M | $213.8M | ||
| Q2 24 | $93.3M | $237.1M | ||
| Q1 24 | $96.7M | $239.2M |
净利润CERTSRI
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $1.5M | $-9.4M | ||
| Q2 25 | $-2.0M | $-9.4M | ||
| Q1 25 | $4.7M | $-7.2M | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $-1.4M | $-7.1M | ||
| Q2 24 | $-12.6M | $2.8M | ||
| Q1 24 | $-4.7M | $-6.1M |
毛利率CERTSRI
| Q4 25 | — | 16.2% | ||
| Q3 25 | — | 20.3% | ||
| Q2 25 | — | 21.5% | ||
| Q1 25 | — | 21.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 20.2% |
营业利润率CERTSRI
| Q4 25 | 0.8% | -14.4% | ||
| Q3 25 | 2.9% | -1.6% | ||
| Q2 25 | 9.1% | -1.1% | ||
| Q1 25 | 7.2% | -1.5% | ||
| Q4 24 | 6.0% | -2.0% | ||
| Q3 24 | 2.7% | 0.1% | ||
| Q2 24 | -9.7% | 1.4% | ||
| Q1 24 | -1.3% | 0.1% |
净利率CERTSRI
| Q4 25 | -5.7% | — | ||
| Q3 25 | 1.5% | -4.5% | ||
| Q2 25 | -1.9% | -4.1% | ||
| Q1 25 | 4.5% | -3.3% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | -1.4% | -3.3% | ||
| Q2 24 | -13.5% | 1.2% | ||
| Q1 24 | -4.8% | -2.6% |
每股收益（稀释后）CERTSRI
| Q4 25 | $-0.04 | $-2.76 | ||
| Q3 25 | $0.01 | $-0.34 | ||
| Q2 25 | $-0.01 | $-0.34 | ||
| Q1 25 | $0.03 | $-0.26 | ||
| Q4 24 | $0.04 | $-0.22 | ||
| Q3 24 | $-0.01 | $-0.26 | ||
| Q2 24 | $-0.08 | $0.10 | ||
| Q1 24 | $-0.03 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.4M | $66.3M |
| 总债务越低越好 | $293.1M | $180.9M |
| 股东权益账面价值 | $1.1B | $179.8M |
| 总资产 | $1.6B | $551.2M |
| 负债/权益比越低杠杆越低 | 0.28× | 1.01× |
8季度趋势，按日历期对齐
现金及短期投资CERTSRI
| Q4 25 | $189.4M | $66.3M | ||
| Q3 25 | $172.7M | $54.0M | ||
| Q2 25 | $162.3M | $49.8M | ||
| Q1 25 | $179.1M | $79.1M | ||
| Q4 24 | $179.2M | $71.8M | ||
| Q3 24 | $233.0M | $54.1M | ||
| Q2 24 | $224.6M | $42.1M | ||
| Q1 24 | $224.8M | $48.4M |
总债务CERTSRI
| Q4 25 | $293.1M | $180.9M | ||
| Q3 25 | $293.5M | — | ||
| Q2 25 | $294.2M | — | ||
| Q1 25 | $294.8M | — | ||
| Q4 24 | $295.4M | $201.6M | ||
| Q3 24 | $296.1M | — | ||
| Q2 24 | $296.7M | — | ||
| Q1 24 | $290.8M | — |
股东权益CERTSRI
| Q4 25 | $1.1B | $179.8M | ||
| Q3 25 | $1.1B | $251.2M | ||
| Q2 25 | $1.1B | $260.5M | ||
| Q1 25 | $1.1B | $253.1M | ||
| Q4 24 | $1.1B | $245.3M | ||
| Q3 24 | $1.1B | $271.4M | ||
| Q2 24 | $1.0B | $270.5M | ||
| Q1 24 | $1.1B | $277.3M |
总资产CERTSRI
| Q4 25 | $1.6B | $551.2M | ||
| Q3 25 | $1.5B | $632.1M | ||
| Q2 25 | $1.5B | $639.4M | ||
| Q1 25 | $1.6B | $657.4M | ||
| Q4 24 | $1.6B | $621.6M | ||
| Q3 24 | $1.5B | $662.5M | ||
| Q2 24 | $1.5B | $666.7M | ||
| Q1 24 | $1.5B | $675.4M |
负债/权益比CERTSRI
| Q4 25 | 0.28× | 1.01× | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.28× | 0.82× | ||
| Q3 24 | 0.28× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.8M | $8.8M |
| 自由现金流经营现金流 - 资本支出 | $27.8M | $2.6M |
| 自由现金流率自由现金流/营收 | 26.8% | 1.3% |
| 资本支出强度资本支出/营收 | 1.0% | 3.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $94.4M | $12.2M |
8季度趋势，按日历期对齐
经营现金流CERTSRI
| Q4 25 | $28.8M | $8.8M | ||
| Q3 25 | $32.3M | $3.6M | ||
| Q2 25 | $17.8M | $10.7M | ||
| Q1 25 | $17.4M | $10.9M | ||
| Q4 24 | $49.4M | $19.2M | ||
| Q3 24 | $17.0M | $10.8M | ||
| Q2 24 | $9.8M | $8.7M | ||
| Q1 24 | $4.3M | $9.1M |
自由现金流CERTSRI
| Q4 25 | $27.8M | $2.6M | ||
| Q3 25 | $32.1M | $-2.7M | ||
| Q2 25 | $17.8M | $7.4M | ||
| Q1 25 | $16.8M | $4.8M | ||
| Q4 24 | $49.0M | $14.0M | ||
| Q3 24 | $16.8M | $4.6M | ||
| Q2 24 | $9.4M | $1.5M | ||
| Q1 24 | $3.7M | $3.3M |
自由现金流率CERTSRI
| Q4 25 | 26.8% | 1.3% | ||
| Q3 25 | 30.7% | -1.3% | ||
| Q2 25 | 17.0% | 3.3% | ||
| Q1 25 | 15.8% | 2.2% | ||
| Q4 24 | 48.8% | 6.4% | ||
| Q3 24 | 17.7% | 2.2% | ||
| Q2 24 | 10.1% | 0.6% | ||
| Q1 24 | 3.8% | 1.4% |
资本支出强度CERTSRI
| Q4 25 | 1.0% | 3.0% | ||
| Q3 25 | 0.2% | 3.0% | ||
| Q2 25 | 0.1% | 1.4% | ||
| Q1 25 | 0.6% | 2.8% | ||
| Q4 24 | 0.4% | 2.4% | ||
| Q3 24 | 0.2% | 2.9% | ||
| Q2 24 | 0.5% | 3.0% | ||
| Q1 24 | 0.6% | 2.4% |
现金转化率CERTSRI
| Q4 25 | — | — | ||
| Q3 25 | 21.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.66× | — | ||
| Q4 24 | 7.51× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.11× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CERT
暂无分部数据
SRI
| Control Devices | $51.7M | 25% |
| Electronics | $38.0M | 19% |
| EE | $34.2M | 17% |
| SE | $28.6M | 14% |
| NL | $24.5M | 12% |
| Stoneridge Brazil | $14.1M | 7% |
| Asia Pacific | $13.1M | 6% |
